1. Home
  2. COCP vs BBGI Comparison

COCP vs BBGI Comparison

Compare COCP & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • BBGI
  • Stock Information
  • Founded
  • COCP 2006
  • BBGI 1961
  • Country
  • COCP United States
  • BBGI United States
  • Employees
  • COCP N/A
  • BBGI N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • BBGI Broadcasting
  • Sector
  • COCP Health Care
  • BBGI Consumer Discretionary
  • Exchange
  • COCP Nasdaq
  • BBGI Nasdaq
  • Market Cap
  • COCP 15.3M
  • BBGI 13.2M
  • IPO Year
  • COCP N/A
  • BBGI 2000
  • Fundamental
  • Price
  • COCP $1.60
  • BBGI $5.71
  • Analyst Decision
  • COCP Strong Buy
  • BBGI
  • Analyst Count
  • COCP 1
  • BBGI 0
  • Target Price
  • COCP $7.00
  • BBGI N/A
  • AVG Volume (30 Days)
  • COCP 17.1K
  • BBGI 3.8K
  • Earning Date
  • COCP 05-12-2025
  • BBGI 05-07-2025
  • Dividend Yield
  • COCP N/A
  • BBGI N/A
  • EPS Growth
  • COCP N/A
  • BBGI N/A
  • EPS
  • COCP N/A
  • BBGI N/A
  • Revenue
  • COCP N/A
  • BBGI $240,291,611.00
  • Revenue This Year
  • COCP N/A
  • BBGI $5.02
  • Revenue Next Year
  • COCP N/A
  • BBGI N/A
  • P/E Ratio
  • COCP N/A
  • BBGI N/A
  • Revenue Growth
  • COCP N/A
  • BBGI N/A
  • 52 Week Low
  • COCP $1.12
  • BBGI $4.80
  • 52 Week High
  • COCP $3.26
  • BBGI $15.20
  • Technical
  • Relative Strength Index (RSI)
  • COCP 57.48
  • BBGI 50.30
  • Support Level
  • COCP $1.49
  • BBGI $5.12
  • Resistance Level
  • COCP $1.74
  • BBGI $6.24
  • Average True Range (ATR)
  • COCP 0.15
  • BBGI 0.43
  • MACD
  • COCP 0.04
  • BBGI 0.09
  • Stochastic Oscillator
  • COCP 63.79
  • BBGI 39.57

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The Company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. The Company owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The Company currently operates three operating segments Audio, Digital and esports.

Share on Social Networks: